LogoLogoMSF Science Portal
  • My saved items
logo

© Médecins Sans Frontières

MSF Science Portal
About MSF Science Portal
About MSF
Contact Us
Frequently Asked Questions (FAQs)
Privacy Policy
Terms of Use

v2.1.4829.produswest2

Journal Article > Research

Single low-dose primaquine for blocking transmission of Plasmodium falciparum malaria - a proposed model-derived age-based regimen for sub-Saharan Africa

Taylor WRJ, Naw HK, Maitland K, Williams TN, Kapulu M, D'Alessandro U, Berkley JA, Bejon P, Okebe J, Achan J, Amambua AN, Affara M, Nwakanma D, Van Geertruyden JP, Mavoko M, Lutumba P, Matangila J, Brasseur P, Piola P, Randremanana R, Lasry E, Fanello CI, Onyamboko MA, Schramm B, Yah Z, Jones JJ, Fairhurst RM, Diakite M, Malenga G, Molyneux M, Rwangacondo C, Obonyo C, Gadisa E, Aseffa A, Loolpapit M, Henry MJ, Dorsey G, John C, Sirima SB, Barnes KI, Kremsner PG, Day NPJ, White NJ, Mukaka M
Download
Download
Abstract
In 2012, the World Health Organization recommended blocking the transmission of Plasmodium falciparum with single low-dose primaquine (SLDPQ, target dose 0.25 mg base/kg body weight), without testing for glucose-6-phosphate dehydrogenase deficiency (G6PDd), when treating patients with uncomplicated falciparum malaria. We sought to develop an age-based SLDPQ regimen that would be suitable for sub-Saharan Africa.
Subject Area
malaria
DOI
10.1186/s12916-017-0990-6
Published Date
18-Jan-2018
PubMed ID
29347975
Languages
English
Journal
BMC Medicine
Volume / Issue / Pages
Volume 16, Issue 1
Issue Date
18-Jan-2018
Dimensions Badge